高危儿童肾母细胞瘤监测:SIOP-Europe共识指南
SIOP-Europe宿主基因组工作组与肾肿瘤研究组基于文献回顾和国际共识会议,更新了高危儿童肾母细胞瘤监测指南,适用于参与高危儿童管理的临床遗传学家、儿科医生、儿科肿瘤医生和放射科医生,并强调将癌症易感综合征患者登记入国家或国际数据库。
要点
- 更新了高危儿童肾母细胞瘤监测指南,涵盖新发现的基因和综合征。
- 指南适用于管理肾母细胞瘤风险儿童的临床遗传学家、儿科医生、儿科肿瘤医生和放射科医生。
- 强调所有癌症易感综合征患者应登记入国家或国际数据库。
核心结论
- 更新了高危儿童肾母细胞瘤监测指南,基于文献回顾和国际共识会议。
研究设计与样本
- 指南制定机构为SIOP-Europe宿主基因组工作组和SIOP肾肿瘤研究组,方法为广泛文献回顾和国际共识会议。
关键数值与推荐
- 指南推荐对高危儿童进行肾母细胞瘤监测,具体监测条款未在摘要中详述。
临床怎么用
- 临床遗传学家、儿科医生、儿科肿瘤医生和放射科医生可依据此指南管理肾母细胞瘤风险儿童。
- 应将所有癌症易感综合征患者登记入国家或国际数据库,以利于未来制定更好的肿瘤风险评估和监测方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since previous consensus-based Wilms tumour (WT) surveillance guidelines were published, novel genes and syndromes associated with WT risk have been identified, and diagnostic molecular tests for previously known syndromes have improved. In view of this, the International Society of Pediatric Oncology (SIOP)-Europe Host Genome Working Group and SIOP Renal Tumour Study Group hereby present updated WT surveillance guidelines after an extensive literature review and international consensus meetings. These guidelines are for use by clinical geneticists, pediatricians, pediatric oncologists and radiologists involved in the care of children at risk of WT. Additionally, we emphasise the need to register all patients with a cancer predisposition syndrome in national or international databases, to enable the development of better tumour risk estimates and tumour surveillance programs in the future.
引用
- Hol JA, Jewell R, Chowdhury T, et al. Wilms tumour surveillance in at-risk children: Literature review and recommendations from the SIOP-Europe Host Genome Working Group and SIOP Renal Tumour Study Group. Eur J Cancer. 2021. PMID: 34134020. doi:10.1016/j.ejca.2021.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。